(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-((1H-indol-3-yl)methyl)-83-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-41-(3-amino-3-oxopropyl)-8,32-bis(4-aminobutyl)-26,74-dibenzyl-23-((S)-sec-butyl)-29,47-bis(2-carboxyethyl)-65-(carboxymethyl)-2-(3-guanidinopropyl)-53-(4-hydroxybenzyl)-71,77-bis((R)-1-hydroxyethyl)-56,59,68-tris(hydroxymethyl)-14,50-diisobutyl-11,62-diisopropyl-20,35,38-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-heptacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-heptacosaazahexaoctacontanedioic acid

Catalog No. :
ACTAZS150
CAS No. :
123475-27-4
Molecular Formula :
C149H225N39O46
Molecular Weight :
3298.67

IUPAC Name:(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-((1H-indol-3-yl)methyl)-83-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-41-(3-amino-3-oxopropyl)-8,32-bis(4-aminobutyl)-26,74-dibenzyl-23-((S)-sec-butyl)-29,47-bis(2-carboxyethyl)-65-(carboxymethyl)-2-(3-guanidinopropyl)-53-(4-hydroxybenzyl)-71,77-bis((R)-1-hydroxyethyl)-56,59,68-tris(hydroxymethyl)-14,50-diisobutyl-11,62-diisopropyl-20,35,38-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-heptacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-heptacosaazahexaoctacontanedioic acid

(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-((1H-indol-3-yl)methyl)-83-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-41-(3-amino-3-oxopropyl)-8,32-bis(4-aminobutyl)-26,74-dibenzyl-23-((S)-sec-butyl)-29,47-bis(2-carboxyethyl)-65-(carboxymethyl)-2-(3-guanidinopropyl)-53-(4-hydroxybenzyl)-71,77-bis((R)-1-hydroxyethyl)-56,59,68-tris(hydroxymethyl)-14,50-diisobutyl-11,62-diisopropyl-20,35,38-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-heptacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-heptacosaazahexaoctacontanedioic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-((1H-indol-3-yl)methyl)-83-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-41-(3-amino-3-oxopropyl)-8,32-bis(4-aminobutyl)-26,74-dibenzyl-23-((S)-sec-butyl)-29,47-bis(2-carboxyethyl)-65-(carboxymethyl)-2-(3-guanidinopropyl)-53-(4-hydroxybenzyl)-71,77-bis((R)-1-hydroxyethyl)-56,59,68-tris(hydroxymethyl)-14,50-diisobutyl-11,62-diisopropyl-20,35,38-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-heptacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-heptacosaazahexaoctacontanedioic acid
IUPAC Name(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-((1H-indol-3-yl)methyl)-83-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-41-(3-amino-3-oxopropyl)-8,32-bis(4-aminobutyl)-26,74-dibenzyl-23-((S)-sec-butyl)-29,47-bis(2-carboxyethyl)-65-(carboxymethyl)-2-(3-guanidinopropyl)-53-(4-hydroxybenzyl)-71,77-bis((R)-1-hydroxyethyl)-56,59,68-tris(hydroxymethyl)-14,50-diisobutyl-11,62-diisopropyl-20,35,38-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-heptacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-heptacosaazahexaoctacontanedioic acid
Molecular FormulaC149H225N39O46
Molecular Weight3298.67
SMILESCC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
InChI KeyNGJOFQZEYQGZMB-KTKZVXAJSA-N
SynonymBeinaglutide;L-Arginine, L-histidyl-L-alanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglycyl-;Benaglutide;L-Arginine, L-histidyl-L-alanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglyc...
CAS No.123475-27-4

Synthetic Route by SureRoute

1. ACTAZS150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTAZS150 route product structure diagram
    ACTAZS150123475-27-4
Inquiry

2. ACTAZS150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTAZS150 route product structure diagram
    ACTAZS150123475-27-4
Inquiry

Comments (0)